Senate Begins Consideration of HR 4521 – COMPETES Act

Yesterday, the Senate began consideration of HR 4521, the America COMPETES Act of 2022. A cloture vote was ordered for Monday evening on the motion to proceed to debate on the bill. There were no amendments offered which is typically a sign on bills like this that no one expects the debate to begin. The bill passed in the House on a very nearly party-line vote so there is unlikely to be 60 votes to begin debate.

This ‘biotechnology bill’ quickly morphed to a major technology spending/regulation package similar in scope to S 1260 that was passed in the Senate. It does contain some interesting cybersecurity provisions.